These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 27781259)

  • 1. [Research progress of serrated polyposis syndrome].
    Dong S; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1197-1200. PubMed ID: 27781259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical subtypes and molecular characteristics of serrated polyposis syndrome.
    Guarinos C; Sánchez-Fortún C; Rodríguez-Soler M; Pérez-Carbonell L; Egoavil C; Juárez M; Serradesanferm A; Bujanda L; Fernández-Bañares F; Cubiella J; de-Castro L; Guerra A; Aguirre E; Herreros-de-Tejada A; Bessa X; Herráiz M; Marín-Gabriel JC; Balmaña J; Cuatrecasas M; Balaguer F; Castells A; Soto JL; Alenda C; Payá A; Jover R
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):705-11; quiz e46. PubMed ID: 23376323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
    Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
    J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
    Murakami T; Sakamoto N; Nagahara A
    World J Gastroenterol; 2018 Aug; 24(29):3250-3259. PubMed ID: 30090005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.
    Tsai JH; Cheng CH; Chen CC; Lin YL; Lin LI; Chen ML; Liau JY
    Histopathology; 2016 May; 68(6):810-8. PubMed ID: 26496853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The alternative way of colorectal cancer developing. The histogenetic and molecular features of serrated lesions (review, continued)].
    Ageĭkina NV; Duvanskiĭ VA; Kniazev MV; Mal'kov PG; Danilova NV; Kharlova OA
    Eksp Klin Gastroenterol; 2014; (7):4-12. PubMed ID: 25842399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
    Young J; Jass JR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serrated pathway in colorectal carcinogenesis.
    Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
    World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.
    Qiu Y; Fu X; Zhang W; Xu Y; Xiao L; Chen X; Shi L; Zhou X; Xia G; Peng Y; Deng M
    J Clin Pathol; 2014 Jun; 67(6):491-8. PubMed ID: 24570042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
    Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
    Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.